Combined lung and liver transplantation: Analysis of a single-center experience

Liver Transplantation

Volumn 20, Issue 1, 2014, Pages 46-53

  Yi, Stephanie G ^a   Burroughs, Sherilyn Gordon ^a   Loebe, Matthias ^b   Scheinin, Scott ^b   Seethamraju, Harish ^c   Jyothula, Soma ^a   Monsour, Howard ^a   McFadden, Robert ^a   Podder, Hemangshu ^a   Saharia, Ashish ^a   Asham, Emad H ^a   Boktour, Maha ^a   Gaber, A Osama ^a   Ghobrial, R Mark ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b Department of Cardiovascular Surgery Department of Medicine ^*  (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CILASTATIN PLUS IMIPENEM; DACLIZUMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TACROLIMUS; VANCOMYCIN;

ACUTE HEMORRHAGIC PANCREATITIS; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BILE DUCT DISEASE; BILE LEAKAGE; CLINICAL ARTICLE; COLD ISCHEMIA; COMBINED LUNG LIVER TRANSPLANTATION; CYSTIC FIBROSIS; DISEASE SEVERITY; DUODENUM PERFORATION; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; ISCHEMIA; LENGTH OF STAY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PANCREAS ISLET TRANSPLANTATION; PATIENT SELECTION; POST TREATMENT SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SEPSIS; SURGICAL MORTALITY; TREATMENT INDICATION; YOUNG ADULT;

ADULT; AGE FACTORS; ALPHA 1-ANTITRYPSIN DEFICIENCY; COLD ISCHEMIA; CYSTIC FIBROSIS; END STAGE LIVER DISEASE; FEMALE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HEPATITIS C; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; ISCHEMIA; LENGTH OF STAY; LIVER TRANSPLANTATION; LUNG; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896544154     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23770     Document Type: Article

References (25)

1. Arnon R, Annunziato RA, Miloh T, Padilla M, Sogawa H, Batemarco L, et al. Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database. Pediatr Transplant 2011; 15: 254-264.
2. Barshes NR, DiBardino DJ, McKenzie ED, Lee TC, Stayer SA, Mallory GB, et al. Combined lung and liver transplantation: the United States experience. Transplantation 2005; 80: 1161-1167.
3. Grannas G, Neipp M, Hoeper MM, Gottlieb J, Lück R, Becker T, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation 2008; 85: 524-531.
4. Couetil JP, Houssin DP, Soubrane O, Chevalier PG, Dousset BE, Loulmet D, et al. Combined lung and liver transplantation in patients with cystic fibrosis: a 4 1/2-year experience. J Thorac Cardiovasc Surg 1995; 110: 1415-1422.
5. Rana A, Robles S, Russo MJ, Halazun KJ, Woodland DC, Witkowski P, et al. The combined organ effect: protection against rejection? Ann Surg 2008; 248: 871-879.
6. Praseedom RK, McNeil KD, Watson CJ, Alexander GJ, Calne RY, Wallwork J, Friend PJ,. Combined transplantation of the heart, lung, and liver. Lancet 2001; 358: 812-813.
7. United Network for Organ Sharing. A guide to calculating the lung allocation score. http://www.unos.org/docs/lung-allocation-score.pdf. Accessed May 2013.
8. United Network for Organ Sharing. Questions & answers for transplant candidates about liver allocation policy. http://www.unos.org/docs/Liver- patient.pdf. Accessed May 2013.
9. Organ Procurement and Transplantation Network. Policy 3.93. Organ allocation to multiple organ transplant candidates. http://optn.transplant.hrsa. gov/PoliciesandBylaws2/policies/pdfs/policy-11.pdf. Accessed August 2013.
10. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD,. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56: 1409-1413.
11. Abu-Elmagd K, Fung J, Bueno J, Martin D, Madariaga JR, Mazariegos G, et al. Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg 2000; 232: 680-687.
12. Busuttil RW, Colonna JO II, Hiatt JR, Brems JJ, el Khoury G, Goldstein LI, et al. The first 100 liver transplants at UCLA. Ann Surg 1987; 206: 387-402.
13. Merlo CA, Weiss ES, Orens JB, Borja MC, Diener-West M, Conte JV, Shah AS,. Impact of U.S. lung allocation score on survival after lung transplantation. J Heart Lung Transplant 2009; 28: 769-775.
14. Horai T, Shigemura N, Gries C, Pilewski J, Bhama JK, Bermudez CA, et al. Lung transplantation for patients with high lung allocation score: single-center experience. Ann Thorac Surg 2012; 93: 1592-1597.
15. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS,. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg 2009; 88: 1757-1764.
16. Scientific Registry of Transplant Recipients. OPTN/SRTR 2011 annual data report: lung. http://srtr.transplant.hrsa.gov/annual-reports/2011/pdf/06-lung- 12.pdf. Accessed May 2013.
17. Scientific Registry of Transplant Recipients. OPTN/SRTR 2011 annual data report: liver. http://srtr.transplant.hrsa.gov/annual-reports/2011/pdf/03- %20liver-12.pdf. Accessed May 2013.
18. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996; 111: 1018-1022.
19. Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85: 771-774.
20. Boussaud V, Guillemain R, Grenet D, Coley N, Souilamas R, Bonnette P, Stern M,. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008; 63: 732-737.
21. Tramper-Stranders GA, van der Ent CK, Slieker MG, Terheggen-Lagro SW, Teding van Berkhout F, Kimpen JL, Wolfs TF,. Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population. Thorax 2006; 61: 689-693.
22. Chaparro C, Kesten S,. Infections in lung transplant recipients. Clin Chest Med 1997; 18: 339-351.
23. Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR,. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997; 155: 1699-1704.
24. Créput C, Durrbach A, Menier C, Guettier C, Samuel D, Dausset J, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39: 587-594.
25. Gugenheim J, Le Thai B, Rouger P, Gigou M, Gane P, Vial MC, et al. Relationship between the liver and lymphocytotoxic alloantibodies in inbred rats. Specific absorption by nonparenchymal liver cells. Transplantation 1988; 45: 474-478.